AIM4
AIM4 is a compound that can inhibit the aggregation of TDP-43. AIM4 has good biocompatibility and anti-inflammatory activity. AIM4 can be used in the research of diseases such as amyotrophic lateral sclerosis[1].
Product Specifications
CAS Number
[1841140-38-2]
UNSPSC
12352005
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Purity
99.07
Smiles
O=C(CN1C=C[N+](CC2=CC=CC3=CC4=CC=CC(C[N+]5=CN(CC(O)=O)C=C5)=C4N=C23)=C1)O.[Br-].[Br-]
Molecular Formula
C25H23Br2N5O4
Molecular Weight
617.29
References & Citations
[1]Revi N, et al. Acridine Benzimidazolium Derivatives Induced Protective Microglia Polarization and In Silico TDP-43 Interaction─Potential Implications for Amyotrophic Lateral Sclerosis. ACS Chem Neurosci. 2025 Mar 19;16 (6) :1103-1116.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-172450/AIM4-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
